Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

Fig. 4

The mean and individual changes in the mitral E/e′ ratio (a–c), left atrial reservoir strain (LASr, d–f), and heart rate (g–i) at rest and during cycle exercise at baseline and after 6 months in both study groups. The bars and squares indicate the means, and the markers (error bars) indicate the standard deviations or 95% confidence intervals

Back to article page